Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice

Peptides

Volumn 43, Issue , 2013, Pages 96-101

  Flick Smith, Helen C ^a   Fox, Marc A ^a   Hamblin, Karleigh A ^a   Richards, Mark I ^a   Jenner, Dominic C ^a   Laws, Thomas R ^a   Phelps, Amanda L ^a   Taylor, Christopher ^a   Harding, Sarah V ^a   Ulaeto, David O ^a   Atkins, Helen S ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Antimicrobial peptide; Francisella tularensis LVS; LL 37; Mice

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P70;

ANIMAL MODEL; ARTICLE; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TULAREMIA;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRANCISELLA TULARENSIS; IMMUNOMODULATION; MACROPHAGES; MICE; MICE, INBRED BALB C; STRUCTURE-ACTIVITY RELATIONSHIP; TULAREMIA;

FRANCISELLA TULARENSIS; MUS;

EID: 84875401341     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.02.024     Document Type: Article

References (32)

1. S.M. Alalwani, J. Sierigk, C. Herr, O. Pinkenburg, R. Gallo, and C. Vogelmeier The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils Eur J Immunol 40 2010 1118 1126
2. L.S. Amer, B.M. Bishop, and M.L. van Hoek Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella Biochem Biophys Res Commun 396 2010 246 251
3. R. Bals, D.J. Weiner, A.D. Moscioni, R.L. Meegalla, and J.M. Wilson Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide Infect Immun 67 1999 6084 6089
4. P.G. Barlow, Y.X. Li, T.S. Wilkinson, D.M.E. Bowdish, Y.E. Lau, and C. Cosseau The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system J Leukoc Biol 80 2006 509 520
5. P.G. Barlow, P. Svoboda, A. Mackellar, A.A. Nash, I.A. York, and J. Pohl Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37 PLoS ONE 6 2011 e25333
6. C.E. Bolger, C.A. Forestal, J.K. Italo, J.L. Benach, and M.B. Furie The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines J Leukoc Biol 77 2005 893 897
7. C. Bosio, H. Bielefeldt-Ohmann, and J. Belisle Active suppression of the pulmonary immune response by Francisella tularensis Schu4 J Immunol 178 2007 4538 4547
8. D.M.E. Bowdish, D.J. Davidson, Y.E. Lau, K. Lee, M.G. Scott, and R.E.W. Hancock Impact of LL-37 on anti-infective immunity J Leukoc Biol 77 2005 451 459
9. K.L. Brown, G.F.T. Poon, D. Birkenhead, O.M. Pena, R. Falsafi, and C. Dahlgren Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses J Immunol 186 2011 5497 5505
10. D. Chiavolini, J. Alroy, C.A. King, P. Jorth, S. Weir, and G. Madico Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia Infect Immun 76 2008 486 496
11. D.J. Davidson, A.J. Currie, G.S.D. Reid, D.M.E. Bowdish, K.L. MacDonald, and R.C. Ma The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization J Immunol 172 2004 1146 1155
12. N.S. Duckett, S. Olmos, D.M. Durrant, and D.W. Metzger Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain Infect Immun 73 2005 2306 2311
13. K.L. Elkins, S.C. Cowley, and C.M. Bosio Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain Microbes Infect 5 2003 135 142
14. K.L. Elkins, T.R. RhinehartJones, S.J. Culkin, D. Yee, and R.K. Winegar Minimal requirements for murine resistance to infection with Francisella tularensis LVS Infect Immun 64 1996 3288 3293
15. M.A. Fox, J.E. Thwaite, D.O. Ulaeto, T.P. Atkins, and H.S. Atkins Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II Peptides 33 2012 197 205
16. J. Hol, L. Wilhelmsen, and G. Haraldsen The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies J Leukoc Biol 87 2010 501 508
17. T. Into, M. Inomata, K. Shibata, and Y. Murakami Effect of the antimicrobial peptide LL-37on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL8 and CXCL10 in human gingival fibroblasts Cell Immunol 264 2010 104 109
18. H. Jenssen, P. Hamill, and R.E. Hancock Peptide antimicrobial agents Clin Microbiol Rev 19 2006 491
19. K. Kurosaka, Q. Chen, F. Yarovinsky, J.J. Oppenheim, and D. Yang Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant J Immunol 174 2005 6257 6265
20. Y.E. Lau, A. Rozek, M.G. Scott, D.L. Goosney, D.J. Davidson, and R.E.W. Hancock Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells Infect Immun 73 2005 583 591
21. M.W. Lisanby, M.K. Swiecki, B.L.P. Dizon, K.J. Pflughoeft, T.M. Koehler, and J.F. Kearney Cathelicidin administration protects mice from Bacillus anthracis spore challenge J Immunol 181 2008 4989 5000
22. C. Mares, S. Ojeda, Q. Li, E. Morris, J. Coalson, and J. Teale Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections Exp Gerontol 45 2010 91 96
23. M. Nelson, R.E. Dean, F.J. Salguero, C. Taylor, P.C. Pearce, and A.J.H. Simpson Development of an acute model of inhalational melioidosis in the comman marmoset (Callithrix jacchus) Int J Exp Pathol 92 2011 428 435
24. M.A. Pammit, V.N. Budhavarapu, E.K. Raulie, K.E. Klose, J.M. Teale, and B.P. Arulanandam Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp novicida infection Antimicrob Agents Chemother 48 2004 4513 4519
25. J. Pistolic, C. Cosseau, Y.X. Li, J. Yu, N.C.J. Filewod, and S. Gellatly Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappa B signaling pathway J. Innate Immun. 1 2009 254 267
26. R.B. Pyles, G.E. Jezek, and T.D. Eaves-Pyles Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection Infect Immun 78 2010 1700 1710
27. F. Schiemann, E. Brandt, R. Gross, B. Lindner, J. Mittelstaedt, and C.P. Sommerhoff The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4 J Immunol 183 2009 2223 2231
28. M.G. Scott, D.J. Davidson, M.R. Gold, D. Bowdish, and R.E.W. Hancock The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses J Immunol 169 2002 3883 3891
29. M. Telepnev, I. Golovliov, and A. Sjostedt Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells Microb Pathog 38 2005 239 247
30. J.E. Thwaite, S. Hibbs, R.W. Titball, and T.P. Atkins Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence Antimicrob Agents Chemother 50 2006 2316 2322
31. J. Turner, Y. Cho, N.N. Dinh, A.J. Waring, and R.I. Lehrer Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils Antimicrob Agents Chemother 62 1998 2206 2214
32. J. Yu, N. Mookherjee, K. Wee, D.M.E. Bowdish, J. Pistolic, and Y.X. Li Host defense peptide LL-37, in synergy with inflammatory mediator IL-1 beta, augments immune responses by multiple pathways J Immunol 179 2007 7684 7691